Moreover, a few recurrently mutated genes involved in the activation of NF-κB were observed in CLL at a low frequency (> 5%) (i.e. mutations in MYD88, BIRC3, NFKBIE) (174–177). Here, NFKBIE is linked to B-cell chronic lymphocytic leukemia.